The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Effect of Early Palliative Care on Chemotherapy Use and End-of-Life Care in Patients With Metastatic Non–Small-Cell Lung Cancer
Abstract
Purpose: Prior research shows that introducing palliative care soon after diagnosis for patients with metastatic non–small-cell lung cancer (NSCLC) is associated with improvements in quality of life, mood, and survival. We sought to investigate whether early palliative care also affects the frequency and timing of chemotherapy use and hospice care for these patients. Patients and Methods: This secondary analysis is based on a randomized controlled trial of 151 patients with newly diagnosed metastatic NSCLC presenting to an outpatient clinic at a tertiary cancer center from June 2006 to July 2009. Participants received either early palliative care integrated with standard oncology care or standard oncology care alone. By 18-month follow-up, 133 participants (88.1%) had died. Outcome measures included: first, number and types of chemotherapy regimens, and second, frequency and timing of chemotherapy administration and hospice referral. Results: The overall number of chemotherapy regimens did not differ significantly by study group. However, compared with those in the standard care group, participants receiving early palliative care had half the odds of receiving chemotherapy within 60 days of death (odds ratio, 0.47; 95% CI, 0.23 to 0.99; P = .05), a longer interval between the last dose of intravenous chemotherapy and death (median, 64.00 days [range, 3 to 406 days] v 40.50 days [range, 6 to 287 days]; P = .02), and higher enrollment in hospice care for longer than 1 week (60.0% [36 of 60 patients] v 33.3% [21 of 63 patients]; P = .004). Conclusion: Although patients with metastatic NSCLC received similar numbers of chemotherapy regimens in the sample, early palliative care optimized the timing of final chemotherapy administration and transition to hospice services, key measures of quality end-of-life care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
Temel, J. S., Greer, J. A., Muzikansky, A., Gallagher, E. R., Admane, S., Jackson, V. A., Dahlin, C. M., Blinderman, C. D., Jacobsen, J., Pirl, W. F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000678 · Cited by 7,482
Self-citationGefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
Maemondo, M., Inoue, A., Kobayashi, K., Sugawara, S., Oizumi, S., Isobe, H., Gemma, A., Harada, M., Yoshizawa, H., Kinoshita, I., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909530 · Cited by 5,525
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
Shepherd, F. A., Rodrigues Pereira, J., Ciuleanu, T., Tan, E. H., Hirsh, V., Thongprasert, S., Campos, D., Maoleekoonpiroj, S., Smylie, M., Martins, R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050753 · Cited by 5,419
Wright, A. A. (2008) · JAMA · doi:10.1001/jama.300.14.1665 · Cited by 2,788
Steinhauser, K. E. (2000) · JAMA · doi:10.1001/jama.284.19.2476 · Cited by 2,514
Hanna, N., Shepherd, F. A., Fossella, F. V., Pereira, J. R., De Marinis, F., von Pawel, J., Gatzemeier, U., Tsao, T. C. Y., Pless, M., Muller, T., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.163 · Cited by 2,426
Bakitas, M., Lyons, K. D., Hegel, M. T., Balan, S., Brokaw, F. C., Seville, J., Hull, J. G., Li, Z., Tosteson, T. D., Byock, I. R., et al. (2009) · JAMA · doi:10.1001/jama.2009.1198 · Cited by 1,726
Family Perspectives on End-of-Life Care at the Last Place of Care
Teno, J. M. (2004) · JAMA · doi:10.1001/jama.291.1.88 · Cited by 1,490
Quality End-of-Life Care: Patients' Perspectives
Singer, P. A., Martin, D. K., & Kelner, M. (1999) · JAMA · doi:10.1001/jama.281.2.163 · Cited by 1,287
Kim, E. S., Hirsh, V., Mok, T., Socinski, M. A., Gervais, R., Wu, Y.-L., Li, L.-Y., Watkins, C. L., Sellers, M. V., Lowe, E. S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61758-4 · Cited by 1,242
Cited by
Ferrell, B. R., Temel, J. S., Temin, S., Alesi, E. R., Balboni, T. A., Basch, E. M., Firn, J. I., Paice, J. A., Peppercorn, J. M., Phillips, T., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.1474 · Cited by 2,117
Self-citationBreast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Bakitas, M. A., Tosteson, T. D., Li, Z., Lyons, K. D., Hull, J. G., Li, Z., Dionne-Odom, J. N., Frost, J., Dragnev, K. H., Hegel, M. T., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.6362 · Cited by 1,216
Integration of oncology and palliative care: a Lancet Oncology Commission
Kaasa, S., Loge, J. H., Aapro, M., Albreht, T., Anderson, R., Bruera, E., Brunelli, C., Caraceni, A., Cervantes, A., Currow, D. C., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30415-7 · Cited by 830
Early palliative care for adults with advanced cancer
Haun, M. W., Estel, S., Rücker, G., Friederich, H.-C., Villalobos, M., Thomas, M., & Hartmann, M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011129.pub2 · Cited by 757
de Moor, J. S., Mariotto, A. B., Parry, C., Alfano, C. M., Padgett, L., Kent, E. E., Forsythe, L., Scoppa, S., Hachey, M., & Rowland, J. H. (2013) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-1356 · Cited by 670
“that early palliative care interventions increase not only quality of life, but also quantity of life (53, 54).”
BackgroundSchnipper, L. E., Smith, T. J., Raghavan, D., Blayney, D. W., Ganz, P. A., Mulvey, T. M., & Wollins, D. S. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.8375 · Cited by 649
Chemotherapy Use, Performance Status, and Quality of Life at the End of Life
Prigerson, H. G., Bao, Y., Shah, M. A., Paulk, M. E., LeBlanc, T. W., Schneider, B. J., Garrido, M. M., Reid, M. C., Berlin, D. A., Adelson, K. B., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.2378 · Cited by 645
Hui, D., Hannon, B. L., Zimmermann, C., & Bruera, E. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21490 · Cited by 430
Curtis, J. R., Back, A. L., Ford, D. W., Downey, L., Shannon, S. E., Doorenbos, A. Z., Kross, E. K., Reinke, L. F., Feemster, L. C., Edlund, B., et al. (2013) · JAMA · doi:10.1001/jama.2013.282081 · Cited by 426
Greer, J. A., Jackson, V. A., Meier, D. E., & Temel, J. S. (2013) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21192 · Cited by 345
Self-citationWright, A. A., Zhang, B., Keating, N. L., Weeks, J. C., & Prigerson, H. G. (2014) · BMJ · doi:10.1136/bmj.g1219 · Cited by 340
Models of Palliative Care Delivery for Patients With Cancer
Hui, D., & Bruera, E. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.18.02123 · Cited by 323
Early Palliative Care in Advanced Lung Cancer: A Qualitative Study
Yoong, J., Park, E. R., Greer, J. A., Jackson, V. A., Gallagher, E. R., Pirl, W. F., Back, A. L., & Temel, J. S. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1874 · Cited by 284
Self-citationEarly Specialty Palliative Care — Translating Data in Oncology into Practice
Parikh, R. B., Kirch, R. A., Smith, T. J., & Temel, J. S. (2013) · New England Journal of Medicine · doi:10.1056/nejmsb1305469 · Cited by 279
Self-citationGorin, S. S., Haggstrom, D., Han, P. K. J., Fairfield, K. M., Krebs, P., & Clauser, S. B. (2017) · Annals of Behavioral Medicine · doi:10.1007/s12160-017-9876-2 · Cited by 272
Hoerger, M., Greer, J. A., Jackson, V. A., Park, E. R., Pirl, W. F., El-Jawahri, A., Gallagher, E. R., Hagan, T., Jacobsen, J., Perry, L. M., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.6676 · Cited by 262
Self-citationUnderstanding and Addressing the Role of Coping in Palliative Care for Patients With Advanced Cancer
Greer, J. A., Applebaum, A. J., Jacobsen, J. C., Temel, J. S., & Jackson, V. A. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.00013 · Cited by 257
Self-citationAssociation between the duration of palliative care service and survival in terminal cancer patients
Lee, Y. J., Yang, J.-H., Lee, J.-W., Yoon, J., Nah, J.-R., Choi, W.-S., & Kim, C.-M. (2015) · Supportive Care in Cancer · doi:10.1007/s00520-014-2444-4 · Cited by 43
Gratitude among advanced cancer patients and their caregivers: The role of early palliative care
Borelli, E., Bigi, S., Potenza, L., Gilioli, F., Artioli, F., Porzio, G., Porro, C. A., Efficace, F., Bruera, E., Luppi, M., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.991250 · Cited by 27
Cappell, K., Sundaram, V., Park, A., Shiraz, P., Gupta, R., Jenkins, P., Periyakoil, V. S. J., & Muffly, L. (2018) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2018.01.014 · Cited by 27
Oncology to specialised palliative home care systematic transition: the Domus randomised trial
Benthien, K., Diasso, P., von Heymann, A., Nordly, M., Kurita, G., Timm, H., Johansen, C., Kjellberg, J., von der Maase, H., & Sjøgren, P. (2020) · BMJ Supportive & Palliative Care · doi:10.1136/bmjspcare-2020-002325 · Cited by 18
Metadata
- Authors
- Greer, J. A., Pirl, W. F., Jackson, V. A., Muzikansky, A., Lennes, I. T., Heist, R. S., Gallagher, E. R., & Temel, J. S.
- Venue
- Journal of Clinical Oncology
- Published
- 2012-02-01
- Volume
- 30
- Issue
- 4
- Pages
- 394-400
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2169678441
- Cited by
- 574
- References
- 30
- FWCI
- 32.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.